KLK3 and prostate cancer: Although the initial diagnosis of prostate cancer is relatively straightforward, as it is based on prostate-specific antigen (PSA) screening and confirmatory biopsy, the accurate staging and detection of recurrent and metastatic disease remains clinically challenging.